Antibody Therapeutics for Life

Notices

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited as a chairman of the session of the antibody therapeutics at BIOPLUS 2018 on September 6-9, 2018.
  • Written by Admin
  • Written date 2019-01-14 11:37:00
  • Inquire 1765

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine 

is invited as a chairman of the session of the antibody therapeutics at BIOPLUS 2018 on September 6-9, 2018.

(https://bioplus.kr/fairDash.do?hl=ENG)

 

 

For investors attending the BIOPLUS 2018, please contact PharmAbcine Investor Relations and business development to schedule a meeting 

with management at sungwoo.kim@pharmabcine.com.

List





Prev PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...
Next PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...